Abstract Title:

Effects of bee venom on cholecystokinin octapeptide-induced acute pancreatitis in rats.

Abstract Source:

Pancreas. 2008 Mar;36(2):e22-9. PMID: 18376296

Abstract Author(s):

Sang-Wan Seo, Won-Seok Jung, Sung-Eon Lee, Chang-Min Choi, Byung-Chul Shin, Eun-Kyung Kim, Kang-Beom Kwon, Seung-Heon Hong, Ki-Jung Yun, Rae-Kil Park, Min-Kyo Shin, Ho-Joon Song, Sung-Joo Park

Article Affiliation:

Department of Herbology, College of Oriental Medicine, Wonkwang University, Iksan, Jeonbuk 570-749, South Korea.

Abstract:

OBJECTIVES: Bee venom (BV) has frequently been used as a remedy for inflammatory diseases. The aim of this study was to investigate the effect of BV on cholecystokinin octapeptide (CCK-8)-induced acute pancreatitis (AP) in rats.

METHODS: The BV pretreatment group: 0.25 mg/kg BV was administered subcutaneously, followed by 75 mug/kg CCK-8 subcutaneously 3 times after 1, 3, and 5 hours. This whole procedure was repeated for 5 days. Control group: CCK-8 subcutaneously 3 times after 1, 3, and 5 hours for 5 days. The BV posttreatment group: CCK-8 subcutaneously 3 times at an interval of 2 hours for 3 days, and then 0.25 mg/kg of BV was administered subcutaneously. Control group: CCK-8 subcutaneously 3 times at an interval of 2 hours for 3 days.

RESULTS: The BV pretreatment and posttreatment ameliorated many of the examined laboratory parameters (the pancreatic weight [PW]/body weight [BW] ratio, the serum amylase and lipase activity) and reduced histological damages in pancreas. Furthermore, BV pretreatment reduced the production of tumor necrosis factor-alpha, interleukin 1, and interleukin 6 and also decreased pancreatic nuclearfactor-kappaB binding activity compared with saline-treated group in the AP model. The BV also increased heat shock protein 60 (HSP60) and heat shock protein 72 (HSP72) compared with the saline-treated group in the AP model.

CONCLUSIONS: These findings suggest that the anti-inflammatory effect of BV in CCK-8-induced AP seems to be mediated by inhibiting nuclear factor-kappaB binding activity, and that BV may have a protective effect against AP.

Print Options


This website is for information purposes only. By providing the information contained herein we are not diagnosing, treating, curing, mitigating, or preventing any type of disease or medical condition. Before beginning any type of natural, integrative or conventional treatment regimen, it is advisable to seek the advice of a licensed healthcare professional.

© Copyright 2008-2024 GreenMedInfo.com, Journal Articles copyright of original owners, MeSH copyright NLM.